Clinical Trial Update: 621 Real World Study [NA]

View source ↗

Summary

Real-world study 621 from Carl Zeiss Meditec AG evaluating outcomes in senile cataract has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Senile Cataract

Snippet

Sponsor: Carl Zeiss Meditec AG | Conditions: Senile Cataract | NA | Status: COMPLETED